<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-11T20:43:36+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>刚刚！百济神州「司妥昔单抗」递交上市申请，拟优先审评</title>
    <updated>2021-01-11T18:19:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/IN4mfbgqgO4KQIfem2tNow</id>
    <link href="https://mp.weixin.qq.com/s/IN4mfbgqgO4KQIfem2tNow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1 类新药！微芯生物「西奥罗尼」III 期临床申请获受理</title>
    <updated>2021-01-11T18:19:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/-iOWl_hNR7KzE0ncV6w4aQ</id>
    <link href="https://mp.weixin.qq.com/s/-iOWl_hNR7KzE0ncV6w4aQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肺癌管线再扩充！贝达药业 EGFR/c-Met 双抗申报临床</title>
    <updated>2021-01-11T18:19:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/OEiWQs1snJfedIyhOsAsGA</id>
    <link href="https://mp.weixin.qq.com/s/OEiWQs1snJfedIyhOsAsGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物 PD-1/4-1BB 双抗启动临床</title>
    <updated>2021-01-11T18:19:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/-XRKTXEMnZ4t06sUUdT2WQ</id>
    <link href="https://mp.weixin.qq.com/s/-XRKTXEMnZ4t06sUUdT2WQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 全球癌症数据：乳腺癌取代肺癌，成为全球第一癌，中国年癌症死亡人数破 300 万</title>
    <updated>2021-01-08T18:48:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/c1pGeeGomtE5WHoWeo4UMQ</id>
    <link href="https://mp.weixin.qq.com/s/c1pGeeGomtE5WHoWeo4UMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科兴新冠疫苗有效率 78%：巴西公布 III 期临床试验数据</title>
    <updated>2021-01-08T18:48:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/zmb1UTn4A5D5ISCpP1CtLg</id>
    <link href="https://mp.weixin.qq.com/s/zmb1UTn4A5D5ISCpP1CtLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「氟唑帕利」新适应症拟优先审评！复发性卵巢癌维持治疗</title>
    <updated>2021-01-08T16:37:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/28eBA4Qtx9uBBmQxHKS5zg</id>
    <link href="https://mp.weixin.qq.com/s/28eBA4Qtx9uBBmQxHKS5zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首款皮下注射 PD-L1！康宁杰瑞/思路迪「恩沃利单抗」拟优先审评</title>
    <updated>2021-01-08T16:37:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/o6bc_dbaEBoQnahI0KIYzg</id>
    <link href="https://mp.weixin.qq.com/s/o6bc_dbaEBoQnahI0KIYzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1 类新药！正大天晴 TQC3721 申报临床，用于慢阻肺和哮喘</title>
    <updated>2021-01-08T16:37:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/GwVzenXzMgTctVS-zfleuQ</id>
    <link href="https://mp.weixin.qq.com/s/GwVzenXzMgTctVS-zfleuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK 艾滋病新药「多替拉韦利匹韦林片」国内报上市</title>
    <updated>2021-01-08T16:37:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/pdIgmjdyy9nohlL7aKKyww</id>
    <link href="https://mp.weixin.qq.com/s/pdIgmjdyy9nohlL7aKKyww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CTLA-4 赛道新选手：和铂医药单抗 HBM4003 启动临床</title>
    <updated>2021-01-08T16:37:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/u6gQTnkJWrQ1t3yd1zr7kw</id>
    <link href="https://mp.weixin.qq.com/s/u6gQTnkJWrQ1t3yd1zr7kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科伦 2020 业绩预告：净利润 8-8.8 亿元，同比下降 14.7%-6.2%</title>
    <updated>2021-01-07T20:12:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/u-sKJFLmjKZJ2C0pWK13MA</id>
    <link href="https://mp.weixin.qq.com/s/u-sKJFLmjKZJ2C0pWK13MA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Insight 数据库新功能来啦！轻松获取项目、靶点、适应症竞争格局</title>
    <updated>2021-01-07T20:12:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/1Y45vewrT63IcySsF03O0w</id>
    <link href="https://mp.weixin.qq.com/s/1Y45vewrT63IcySsF03O0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药「度他雄胺软胶囊」获批！国内第二家</title>
    <updated>2021-01-07T20:12:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/N8UEI11wBtr0jJb-GRQoig</id>
    <link href="https://mp.weixin.qq.com/s/N8UEI11wBtr0jJb-GRQoig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>帕瑞昔布钠又有 3 家过评，第四批国采竞争格局新变化</title>
    <updated>2021-01-07T20:12:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/PJJOnV5OJISmrE0VJaK3Ww</id>
    <link href="https://mp.weixin.qq.com/s/PJJOnV5OJISmrE0VJaK3Ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超 8 亿美元引进！云顶新耀 Trop-2 靶向 ADC 即将启动 III 期临床</title>
    <updated>2021-01-07T20:12:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/N_9keRyoHlZ4ts0jA-wM9g</id>
    <link href="https://mp.weixin.qq.com/s/N_9keRyoHlZ4ts0jA-wM9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 年这些新药在国内获批：抗肿瘤、罕见病药物占比近半</title>
    <updated>2021-01-06T18:46:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/uXTRq59xJT2UDlQAFRgpCQ</id>
    <link href="https://mp.weixin.qq.com/s/uXTRq59xJT2UDlQAFRgpCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这 9 个参比制剂未通过审议，已累计 96 个（附全量表格）</title>
    <updated>2021-01-06T18:46:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/0yim2XcvqsddEdVKsZBuaA</id>
    <link href="https://mp.weixin.qq.com/s/0yim2XcvqsddEdVKsZBuaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又一款 HER2 靶向 ADC 药物申报临床，国内 ADC 靶点扎堆？</title>
    <updated>2021-01-06T18:46:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/XqqFmYknPVKJ3u7n7sKVCg</id>
    <link href="https://mp.weixin.qq.com/s/XqqFmYknPVKJ3u7n7sKVCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光 PI3Kδ 抑制剂启动临床</title>
    <updated>2021-01-06T18:46:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/IAd58YlEjana64j6b3YowA</id>
    <link href="https://mp.weixin.qq.com/s/IAd58YlEjana64j6b3YowA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>